Oncology Institute, Inc. 8-K — AI Bull & Bear Analysis

The Oncology Institute's 8-K filing confirms that a previously disclosed vendor-related cybersecurity incident resulted in unauthorized access to patient data. While the company asserts that its internal systems and quality of care remained unaffected, it now faces the challenge of managing patient remediation and potential legal claims. The ultimate impact on the company will depend on the scale of the data exfiltration and the success of its efforts to recover damages from the responsible third-party vendor.